net impact on U.S. health insurers is quite the opposite and is "going to be positive for them," added Jeff Jonas of Gabelli Funds. "The costs from COVID-19 are going to be actually very small and more than outweighed by the deferral of elective procedures." $UNH, $CI, $ANTM